Patents by Inventor Hajime Shibuya

Hajime Shibuya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11969830
    Abstract: An aluminum alloy brazing sheet including a core material, a sacrificial material provided on one surface of the core material, a brazing filler material provided on the other surface side of the core material, and an intermediate layer provided between the core material and the brazing filler material. The core material contains Si: 0.30 to 1.00 mass %, Mn: 0.50 to 2.00 mass %, Cu: 0.60 to 1.20 mass %, Mg: 0.05 to 0.80 mass %, and Al. The sacrificial material contains Si: 0.10 to 1.20 mass %, Zn: 2.00 to 7.00 mass %, Mn: 0.40 mass % or less, and Al. The intermediate layer contains Si: 0.05 to 1.20 mass %, Mn: 0.50 to 2.00 mass %, Cu: 0.10 to 1.20 mass %, and Al.
    Type: Grant
    Filed: January 29, 2021
    Date of Patent: April 30, 2024
    Assignee: Kobe Steel, Ltd.
    Inventors: Tatsuki Hashimoto, Kenichiro Yoshida, Yuji Shibuya, Akihiro Tsuruno, Yoshikazu Miyano, Hajime Sugito, Michiyasu Yamamoto, Masayuki Makita, Arisu Fujii, Shin Takewaka, Hayaki Teramoto, Koichi Yamamoto, Toshihide Ninagawa
  • Patent number: 8648061
    Abstract: The use of polyunsaturated fatty acids of the ?-3 series such as eicosapentaenoic acid (EPA, C20:5 ?-3), docosahexaenoic acid (DHA, C22:6 ?-3), or their pharmaceutically acceptable derivatives is described for the primary prevention of major cardiovascular events in subjects who have not undergone previous infarct episodes.
    Type: Grant
    Filed: September 29, 2009
    Date of Patent: February 11, 2014
    Assignee: Pro Aparts Investimentos E. Consultoria LDA.
    Inventor: Hajime Shibuya
  • Publication number: 20100016428
    Abstract: The use of polyunsaturated fatty acids of the ?-3 series such as eicosapentaenoic acid (EPA, C20:5 ?-3), docosahexaenoic acid (DHA, C22:6 ?-3), or their pharmaceutically acceptable derivatives is described for the primary prevention of major cardiovascular events in subjects who have not undergone previous infarct episodes.
    Type: Application
    Filed: September 29, 2009
    Publication date: January 21, 2010
    Applicant: PRO APARTS INVESTIMENTOS E CONSULTORIA LDA AV. ARRIAGA
    Inventor: Hajime SHIBUYA
  • Patent number: 7619002
    Abstract: The use of polyunsaturated fatty acids of the .omega.-3 series such as eicosapentaenoic acid (EPA, C.sub.20:5 .omega.-3), docosahexaenoic acid (DHA, C.sub.22:6 .omega.-3), or their pharmaceutically acceptable derivatives is described for the primary prevention of major cardiovascular events in subjects who have not undergone previous infarct episodes.
    Type: Grant
    Filed: November 19, 2007
    Date of Patent: November 17, 2009
    Assignee: Pro Aparts Investimentos E Consultoria LDA. AV. Arriaga
    Inventor: Hajime Shibuya
  • Patent number: 7553870
    Abstract: The use of polyunsaturated fatty acids of the ?-3 series such as eicosapentaenoic acid (EPA, C20:5 ?-3), docosahexaenoic acid (DHA, C22:6 ?-3), or their pharmaceutically acceptable derivatives is described for the primary prevention of major cardiovascular events in subjects who have not undergone previous infarct episodes.
    Type: Grant
    Filed: February 17, 2004
    Date of Patent: June 30, 2009
    Assignee: Pro Aparts Investimentos E Consultoria LDA
    Inventor: Hajime Shibuya
  • Publication number: 20080269331
    Abstract: The use of polyunsaturated fatty acids of the .omega.-3 series such as eicosapentaenoic acid (EPA, C.sub.20:5 .omega.-3), docosahexaenoic acid (DHA, C.sub.22:6 .omega.-3), or their pharmaceutically acceptable derivatives is described for the primary prevention of major cardiovascular events in subjects who have not undergone previous infarct episodes.
    Type: Application
    Filed: November 19, 2007
    Publication date: October 30, 2008
    Inventor: Hajime Shibuya
  • Publication number: 20040162349
    Abstract: The use of polyunsaturated fatty acids of the &ohgr;-3 series such as eicosapentaenoic acid (EPA, C20:5 &ohgr;-3), docosahexaenoic acid (DHA, C22:6 &ohgr;-3), or their pharmaceutically acceptable derivatives is described for the primary prevention of major cardiovascular events in subjects who have not undergone previous infarct episodes.
    Type: Application
    Filed: February 17, 2004
    Publication date: August 19, 2004
    Applicant: QUATEX N.V.
    Inventor: Hajime Shibuya
  • Publication number: 20030100610
    Abstract: The use of polyunsaturated fatty acids of the &ohgr;-3 series such as eicosapentaenoic acid (EPA, C20:5 &ohgr;-3), docosahexaenoic acid (DHA, C22:6 &ohgr;-3), or their pharmaceutically acceptable derivatives is described for the primary prevention of major cardiovascular events in subjects who have not undergone previous infarct episodes.
    Type: Application
    Filed: October 28, 2002
    Publication date: May 29, 2003
    Applicant: QUATEX N.V.
    Inventor: Hajime Shibuya
  • Patent number: 4305956
    Abstract: A miticidal method comprises applying a miticidal composition comprising Lysocellin having the formula ##STR1## or its salt or ester.
    Type: Grant
    Filed: May 15, 1980
    Date of Patent: December 15, 1981
    Assignee: Kaken Chemical Co., Ltd.
    Inventors: Hajime Shibuya, Yukio Inoue, Shiro Okuda, Makoto Hattori
  • Patent number: 4066781
    Abstract: Salinomycin is applied as an active ingredient of a miticidal composition to mites.
    Type: Grant
    Filed: January 27, 1977
    Date of Patent: January 3, 1978
    Assignee: Kaken Chemical Co., Ltd.
    Inventors: Hajime Shibuya, Shiroh Shirato